Carafate maintenance claim
Executive Summary
Marion Merrell Dow's application for use of its ulcer drug for maintenance therapy of healed duodenal ulcers recently gained "approvable" status at FDA. Carafate is approved for short-term (up to eight weeks) treatment of duodenal ulcers.